BIO — Biome Australia Share Price
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro CapMomentum Trap
- AU$27.24m
- AU$26.52m
- AU$7.63m
- 35
- 27
- 94
- 53
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.02 | ||
| Price to Tang. Book | 4.02 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 4.37 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -88.17% | ||
| Return on Equity | -142.96% | ||
| Operating Margin | -103.36% | ||
Financial Summary
| Year End 30th Jun | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | n/a | 0.39 | 0.97 | 2.62 | 4.39 | 7 | 10.2 | 124.62% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Biome Australia Ltd is an Australia-based microbiome health company. It develops, licenses, commercializes and markets evidence-based, complementary medicines, including nutraceuticals (food-based vitamins and weight management products) and live biotherapeutics (probiotics). It markets and distributes clinically researched products developed in conjunction with its strategic partners. Its products are marketed under three brands: Activated Probiotics, Activated Nutrients and Activated X Performance. Its products are distributed through community pharmacies, independent health practitioners and online direct to consumer channels. The Company distributes its products in Australia, New Zealand and the United Kingdom. It offers biotherapeutic products to help prevent and support the management of various health concerns, including low mood and sleep, bone health, iron malabsorption, mild eczema and irritable bowel syndrome (IBS), through randomized double-blind placebo-controlled trails.
Directors
- Ilario Faenza NEC
- Michael Sven Ola Oredsson CEO
- Blair William Brabin Norfolk FDR
- Chee Yong Loh CFO
- Jaroslav Boublik CSO
- Last Annual
- June 30th, 2022
- Last Interim
- December 31st, 2022
- Incorporated
- July 6th, 2018
- Public Since
- October 22nd, 2021
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 199,909,857
- Address
- 16 Dover Street, Cremorne, MELBOURNE, 3121
- Web
- https://biomeaustralia.com/
- Phone
- +61 390175800
- Auditors
- JTP Assurance
Upcoming Events for BIO
Similar to BIO
Acrux
Australian Stock Exchange - SEATS
AFT Pharmaceuticals
Australian Stock Exchange - SEATS
Auscann group
Australian Stock Exchange - SEATS
Botanix Pharmaceuticals
Australian Stock Exchange - SEATS
Cann Global
Australian Stock Exchange - SEATS
FAQ
What is the Biome Australia share price?
As of Today at 19:04 UTC, shares in Biome Australia are trading at AU$0.10. This share price information is delayed by 15 minutes.
How has the Biome Australia share price performed this year?
Shares in Biome Australia last closed at AU$0.10 and the price had moved by +17.07% over the past 365 days. In terms of relative price strength the Biome Australia share price has outperformed the ASX All Ordinaries Index by +8.87% over the past year.
What are the analyst and broker recommendations for Biome Australia?
The overall consensus recommendation for Biome Australia is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Biome Australia dividend yield?
Biome Australia does not currently pay a dividend.
Does Biome Australia pay a dividend?
Biome Australia does not currently pay a dividend.
When does Biome Australia next pay dividends?
Biome Australia does not currently pay a dividend.
How do I buy Biome Australia shares?
To buy shares in Biome Australia you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Biome Australia?
As of the previous close price of AU$0.10, shares in Biome Australia had a market capitalisation of AU$19.19m.
Where are Biome Australia shares listed?
Here are the trading details for Biome Australia:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: BIO
What kind of share is Biome Australia?
Based on an overall assessment of its quality, value and momentum Biome Australia is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Biome Australia share price forecast for 2023?
The analyst consensus target price for shares in Biome Australia is AU$0.16. That is 66.67% above the last closing price of AU$0.10.
Analysts covering Biome Australia currently have a consensus Earnings Per Share (EPS) forecast of -AU$0.01 for the next financial year.
What is the trend in the Biome Australia share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biome Australia. Over the past six months, its share price has outperformed the ASX All Ordinaries Index by +53.07%.
As of the last closing price of AU$0.10, shares in Biome Australia were trading +24.16% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Biome Australia PE Ratio?
The Biome Australia PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.10.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Biome Australia?
Biome Australia's management team is headed by:
- Ilario Faenza - NEC
- Michael Sven Ola Oredsson - CEO
- Blair William Brabin Norfolk - FDR
- Chee Yong Loh - CFO
- Jaroslav Boublik - CSO